Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × inavolisib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 8 Tumor-Agnostic 2 Other solid neoplasm 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Metastatic Castration-Resistant Prostate Cancer 1

Interventions

Magnetic Resonance Spectroscopy 85 Specimen Handling 70 pembrolizumab 64 enzalutamide 50 Radiosurgery 45 Docetaxel 43 Radiotherapy 42 Gemcitabine 40 Androgen Antagonists 39 Nivolumab 31 darolutamide 30 Cisplatin 30 Abiraterone Acetate 29 Prednisone 28 Pluvicto 27 Carboplatin 27 Biopsy 26 Standard of Care 25 apalutamide 24 Blood Specimen Collection 23 enfortumab vedotin 22 cabozantinib 21 Radiation 21 abiraterone 17 Surveys and Questionnaires 17 Leuprolide 17 Ipilimumab 17 gallium 68 PSMA-11 15 X-Rays 14 relugolix 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07287150 2026-03-05

InavoPC

Hoffmann-La Roche

Phase 2 Recruiting

Metastatic Castration-Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡